AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.


Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Telephone: +64 9 488 0232
Facsimile: n/a
Website: www.aftpharm.com
First Listed: 22/12/2015
Balance Date: 31 March
AGM: 04/08/2023

Directors and Executives

Hartley Atkinson
Executive Director
Marree Atkinson
Executive Director
Anita Baldauf
Independent Director
David Flacks
Chairman
Andrew Lane
Director
Malcolm Tubby
CFO / Company Secretary
Ted Witek
Independent Non-Executive Director

Announcements

Title Date Type
NEW YEAR LETTER TO INVESTORS Mon, Jan 13 2025 08:30 am GENERAL
Disclosure of Directors and Senior Managers Relevant Intere Mon, Dec 02 2024 02:45 pm SHINTR
Disclosure of Directors and Senior Managers Relevant Int Wed, Nov 27 2024 04:37 pm SHINTR
Disclosure of Directors and Senior Managers Relevant Int Wed, Nov 27 2024 04:37 pm SHINTR
AFT reports record sales and invests for growth Thu, Nov 21 2024 08:46 am HALFYR
AFT appoints Allison Yorston as independent director Wed, Nov 13 2024 08:30 am ADMIN
SPH Notice - Accident Compensation Corporation (ACC) Thu, Nov 07 2024 03:52 pm SHINTR
AFT trading update Fri, Nov 01 2024 08:40 am GENERAL
AFT enters late-stage R&D agreement for a novel injectable Mon, Oct 21 2024 08:37 am GENERAL
Interim results announcement Thurs Nov 21 2024 Fri, Oct 11 2024 05:08 pm GENERAL

Major Holdings Announcements

Date Name No. Held % Current
16/09/20 Forsyth Barr Group Limited and Fors 1,617,818 71.25 1.55
15/06/20 Hartley Campbell Atkinson and Colin 72,031,609 72.60 69.82
15/06/20 The CRG Persons - 15.99 -
25/05/17 AFT Pharmaceuticals Limited - 72.34 -

Director’s Interests Announcements

Date Name No. Held % Details Other
18/09/23 Jon Lamb 271,314 - - -
14/04/21 Malcolm Tubby 143,892 - - -
10/08/20 Hartley Atkinson 72,899,435 - - -
03/07/20 David Flacks 178,764 - - -
22/08/18 James Burns 125,417 - - -
19/06/17 John Douglas Wilson 56,689 - - -

Analysts’ Forecasts

profit2021 profit2022 eps2021 dps2021 sales2021 ebit2021 ebitda2021
mean 13.7 13.1 2.0 191.3 22.0 24.6
high 13.7 13.1 2.0 191.3 22.0 24.6
low 13.7 13.1 2.0 191.3 22.0 24.6
sample 1 0 1 1 1 1 1

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/07/2023


Markets News

Cross-border rules on aviation emissions give airlines easy ride
Markets

Cross-border rules on aviation emissions give airlines easy ride

Around 80% of Air NZ's emissions from jet fuel are from international flights.

Property

Analysts expect RV companies to raise equity

“We expect investor support for a capital raise," Jarden's Arie Dekker said.

Analysts expect RV companies to raise equity
Markets Best of BusinessDesk

Rate decision odds are tight, NZD set for a wild ride

It did turn out to be an understatement. 

Rate decision odds are tight, NZD set for a wild ride
Markets

NZD outlook: 2025 more about surviving

The kiwi shed more than 11% in 2024, and we already see more downsides. 

NZD outlook: 2025 more about surviving
Markets Market close

NZ sharemarket up on economic recovery news

The S&P/NZX 50 Index closed at 12,884.38, up 57.05 points or 0.44%.

Graham Skellern 14 Jan 2025
NZ sharemarket up on economic recovery news